Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
9 8 Search
2025
AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis
Advanced Science
2025
Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases
BMB Reports
2021
Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial–Mesenchymal Transition (EMT)
Cell Biochemistry and Biophysics
2021
Suberoylanilide hydroxamic acid inhibits LX2 cells proliferation via decreasing yes-associated protein/transcriptional coactivator with PDZ-binding motif proteins
Turkish Journal of Biochemistry
2020
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
Cells
2019
Expression of neuropeptide Y is increased in an activated human HSC cell line
Scientific Reports
2018
Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway
Hepatobiliary & Pancreatic Diseases International
2017
Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
Clinical Epigenetics
2017
Histone deacetylase inhibitors promoteeNOSexpression in vascular smooth muscle cells and suppress hypoxia‐induced cell growth
Journal of Cellular and Molecular Medicine